Literature DB >> 23736914

A possible role of soluble HLA-I molecule in the immunomodulatory effects of therapeutic apheresis.

Massimo Ghio1, Paola Contini1, Filippo Ansaldi2, Gianluca Ubezio1, Maurizio Setti1, Marco Risso3, Gino Tripodi3.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23736914      PMCID： PMC3934267          DOI： 10.2450/2013.0026-13

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  4 in total

1.  Birth of the concept and the development of extracorporeal immunomodulation.

Authors:  Tetsuzo Agishi
Journal:  Ther Apher       Date:  2002-08

2.  Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis.

Authors:  James W Smith; Robert Weinstein; Krista L Hillyer
Journal:  Transfusion       Date:  2003-06       Impact factor: 3.157

Review 3.  Blood-membrane interactions during dialysis.

Authors:  Zhongping Huang; Dayong Gao; Jeffrey J Letteri; William R Clark
Journal:  Semin Dial       Date:  2009 Nov-Dec       Impact factor: 3.455

Review 4.  Therapeutic apheresis: history, clinical application, and lingering uncertainties.

Authors:  Bruce C McLeod
Journal:  Transfusion       Date:  2009-11-20       Impact factor: 3.157
  4 in total
  6 in total

1.  Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.

Authors:  Lidia Stork; David Ellenberger; Tim Beißbarth; Tim Friede; Claudia F Lucchinetti; Wolfgang Brück; Imke Metz
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

2.  Transient inhibition of neutrophil migration following plasma or plasma-platelet apheresis donation procedures.

Authors:  Massimo Ghio; Maria Bertolotto; Luciano Ottonello; Paola Contini; Gianluca Ubezio; Gino Tripodi
Journal:  Blood Transfus       Date:  2014-11-25       Impact factor: 3.443

3.  Transient transforming growth factor β1 modulation in monocytes and natural killer cells following plasma or plasma-platelet apheresis donation procedures.

Authors:  Massimo Ghio; Paola Contini; Gianluca Ubezio; Filippo Ansaldi; Maurizio Setti; Gino Tripodi
Journal:  Blood Transfus       Date:  2015-01-30       Impact factor: 3.443

4.  Donor neutrophil activation and transforming growth factor-β1 modulation induced by donor apheresis procedures.

Authors:  Massimo Ghio; Paola Contini; Filippo Ansaldi; Gianluca Ubezio; Maurizio Setti; Marco Risso; Gino Tripodi
Journal:  Blood Transfus       Date:  2014-10       Impact factor: 3.443

5.  Allostimulatory capacity of conditionally immortalized proximal tubule cell lines for bioartificial kidney application.

Authors:  Milos Mihajlovic; Lambertus P van den Heuvel; Joost G Hoenderop; Jitske Jansen; Martijn J Wilmer; Annemarie J F Westheim; Wil A Allebes; Dimitrios Stamatialis; Luuk B Hilbrands; Rosalinde Masereeuw
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

6.  Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.

Authors:  Guro Kristin Melve; Elisabeth Ersvaer; Geir Egil Eide; Einar K Kristoffersen; Øystein Bruserud
Journal:  Front Immunol       Date:  2018-05-02       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.